ERCC1 BRCA1 in non-small cell lung cancer and cisplatin resistance in Progress.docVIP

ERCC1 BRCA1 in non-small cell lung cancer and cisplatin resistance in Progress.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
ERCC1 BRCA1 in non-small cell lung cancer and cisplatin resistance in Progress

 PAGE \* MERGEFORMAT 13 ERCC1 BRCA1 in non-small cell lung cancer and cisplatin resistance in Progress [Keywords:] ERCC1 BRCA1 non-small cell lung cancer and cisplatin resistance Lung cancer is the most worldwide cancer mortality [1], according to pathological types, lung cancer diagnosed in about 80% of non-small cell lung cancer, newly diagnosed each year in the United States NSCLC, 75% of patients had surgical treatment can not be [2], chemotherapy and radiotherapy for these patients is the main method of treatment. but the tumor cells to chemotherapeutic drug resistance often lead to treatment failure. NSCLC tumor cells now based chemotherapy drug cisplatin resistance herbs and mismatch excision repair protein, the relationship between breast cancer susceptibility gene research status and prospects are reviewed. A mechanism of cisplatin Cisplatin cytotoxicity on tumor cells mainly through the formation of platinum-DNA adducts. The main targets of cisplatin is DNA, into the tumor cells after cisplatin hydrolysis to ammonia diclofenac double platinum, and then the formation of cisplatin with cellular DNA -DNA adducts affect cell DNA replication and transcription, leading to DNA damage [3]. cisplatin adduct formation of mainly 1 and 2 cross-linking between chains, accounting for 90%, a small number of 1, 3 chains crosslinking, long chain, and DNA2 protein cross-linking cross-linking. 2, mismatch excision repair protein 1 (ERCC1) 2.1 nucleotide excision repair Nucleotide excision repair (nucleotide excision repair, NER) is the cause of cisplatin resistance in an important mechanism. NER is an important way to DNA repair, which repair DNA damage in the bulk play an important role [4], including UV dimers, polycyclic aromatic hydrocarbons, and other heavy metals in cisplatin-induced DNA damage. NER pathway is a complex process, involving more than 30 peptides, NER proteins can be divided into two groups: one group was DNA damage identificatio

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档